338 related articles for article (PubMed ID: 1670762)
21. Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.
Davis LM; Harris C; Tang L; Doherty P; Hraber P; Sakai Y; Bocklage T; Doeden K; Hall B; Alsobrook J; Rabinowitz I; Williams TM; Hozier J
J Mol Diagn; 2007 Jul; 9(3):327-36. PubMed ID: 17591932
[TBL] [Abstract][Full Text] [Related]
22. [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].
Yuan ZY; Wang SS; Gao Y; Su ZY; Luo WB; Guan ZZ
Ai Zheng; 2008 Jun; 27(6):561-5. PubMed ID: 18570725
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.
Mizell J; Smith M; Li BD; Ampil F; Chu QD
Ann Surg Oncol; 2009 Oct; 16(10):2711-6. PubMed ID: 19593633
[TBL] [Abstract][Full Text] [Related]
24. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
[TBL] [Abstract][Full Text] [Related]
25. ErbB-2 expression and its association with other biological parameters of breast cancer among Indian women.
Vaidyanathan K; Kumar P; Reddy CO; Deshmane V; Somasundaram K; Mukherjee G
Indian J Cancer; 2010; 47(1):8-15. PubMed ID: 20071783
[TBL] [Abstract][Full Text] [Related]
26. Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer.
Koliadi A; Nilsson C; Holmqvist M; Holmberg L; de La Torre M; Wärnberg F; Fjällskog ML
Acta Oncol; 2010 Aug; 49(6):816-20. PubMed ID: 20307242
[TBL] [Abstract][Full Text] [Related]
27. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
Meenakshi A; Kumar RS; Kumar NS
J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
[TBL] [Abstract][Full Text] [Related]
28. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
Press MF; Bernstein L; Thomas PA; Meisner LF; Zhou JY; Ma Y; Hung G; Robinson RA; Harris C; El-Naggar A; Slamon DJ; Phillips RN; Ross JS; Wolman SR; Flom KJ
J Clin Oncol; 1997 Aug; 15(8):2894-904. PubMed ID: 9256133
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of breast cancer in young and old women based on clinicopathological features].
Székely B; Madaras L; Szentmártoni G; Szász AM; Baranyák Z; Szittya L; Torgyík L; Zergényi E; Borbényi E; Kenessey I; Korompay A; Langmár Z; Bánhidy F; Kulka J; Dank M
Magy Onkol; 2010 Mar; 54(1):19-26. PubMed ID: 20350864
[TBL] [Abstract][Full Text] [Related]
30. PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer.
Moor AE; Guevara C; Altermatt HJ; Warth R; Jaggi R; Aebi S
Pathobiology; 2011; 78(3):140-8. PubMed ID: 21613801
[TBL] [Abstract][Full Text] [Related]
31. [Overexpression of c-erbB-2 gene product is associated with poor prognosis factors in breast carcinoma].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):349-53. PubMed ID: 14755939
[TBL] [Abstract][Full Text] [Related]
32. GRB7 protein over-expression and clinical outcome in breast cancer.
Ramsey B; Bai T; Hanlon Newell A; Troxell M; Park B; Olson S; Keenan E; Luoh SW
Breast Cancer Res Treat; 2011 Jun; 127(3):659-69. PubMed ID: 20635137
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of the 70-gene MammaPrint profile in a Japanese population.
Ishitobi M; Goranova TE; Komoike Y; Motomura K; Koyama H; Glas AM; van Lienen E; Inaji H; Van't Veer LJ; Kato K
Jpn J Clin Oncol; 2010 Jun; 40(6):508-12. PubMed ID: 20110242
[TBL] [Abstract][Full Text] [Related]
34. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
[TBL] [Abstract][Full Text] [Related]
35. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
Fujita N; Nakayama T; Yamamoto N; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Morimoto K; Tamaki Y; Noguchi S
Oncology; 2012; 83(5):273-82. PubMed ID: 22964822
[TBL] [Abstract][Full Text] [Related]
36. ZBTB7 overexpression contributes to malignancy in breast cancer.
Qu H; Qu D; Chen F; Zhang Z; Liu B; Liu H
Cancer Invest; 2010 Jul; 28(6):672-8. PubMed ID: 20394500
[TBL] [Abstract][Full Text] [Related]
37. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.
Andrulis IL; Bull SB; Blackstein ME; Sutherland D; Mak C; Sidlofsky S; Pritzker KP; Hartwick RW; Hanna W; Lickley L; Wilkinson R; Qizilbash A; Ambus U; Lipa M; Weizel H; Katz A; Baida M; Mariz S; Stoik G; Dacamara P; Strongitharm D; Geddie W; McCready D
J Clin Oncol; 1998 Apr; 16(4):1340-9. PubMed ID: 9552035
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer.
Depowski PL; Brien TP; Sheehan CE; Stylos S; Johnson RL; Ross JS
Am J Clin Pathol; 1999 Oct; 112(4):459-69. PubMed ID: 10510669
[TBL] [Abstract][Full Text] [Related]
39. INT-2 gene amplification in differentiated human thyroid cancer.
Schulte KM; Niederacher D; An HX; Staudt S; Simon D; Beckmann MW; Goretzki PE
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():101-4. PubMed ID: 8981013
[TBL] [Abstract][Full Text] [Related]
40. Insights from mixture cure modeling of molecular markers for prognosis in breast cancer.
Yilmaz YE; Lawless JF; Andrulis IL; Bull SB
J Clin Oncol; 2013 Jun; 31(16):2047-54. PubMed ID: 23630217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
